feed,title,long_url,short_url
Benzinga,"OKYO Pharma Reports First Patient Visit For Phase 2 Trial Of OK-101, To Fulfill One Of The Two Phase 3 Studies Required For FDA Approval If Successful",https://benzinga.com/general/biotech/23/05/32184850/okyo-pharma-reports-first-patient-visit-for-phase-2-trial-of-ok-101-to-fulfill-one-of-the-two-pha,https://da.gd/MU4ZJ
